Alzheimer Fund

Lab of Microbiology & Immunology Professor Terry Connell.

Support research, education, training and other activities related to Alzheimer’s Disease.

The purpose of this fund is to provide financial support for a variety of activities within the Department of Neurology in the area of Alzheimer’s Disease and Memory Disorders. 

The Department of Neurology is part of UB’s Jacobs School of Medicine and Biomedical Sciences.

At UB, our pre-eminent neurological team integrates innovative, compassionate patient care with interdisciplinary research, while training more than 100 medical students, neurology residents and neurology fellows each year.

The department includes a comprehensive Alzheimer’s Disease and Memory Disorders Center, in which students build specialized knowledge of common neurodegenerative diseases, including Alzheimer’s disease, mixed dementia and other conditions. Specifically, students learn how to identify clinical presentations, how to monitor drug effectiveness, and how to assist patients and their families, among other skills.

In the world of medicine, there is always more that we can do. More physicians we can train. More discoveries we can make. More lives we can save. Now, even as we celebrate all we have recently achieved, we continue to look forward to the possibilities ahead. Bold ambitions require big investments—and generous support. Together, we will continue to build on our shared success and lead the way toward the future of medicine.

Make a Difference Now

Other Jacobs School of Medicine and Biomedical Sciences Funds

News from the Jacobs School of Medicine and Biomedical Sciences

  • PhD White Coat Ceremony Honors Student Advancement
    6/13/23

    The Office of Biomedical Education conducted its seventh annual white coat ceremony to recognize 23 students from the Class of 2022-2023 in the PhD Program in Biomedical Sciences (PPBS) and two students from the MD-PhD Program who are matching to their doctoral laboratories.

  • Crane Hoists Massive MRI Into CTRC
    6/26/23

    UB is the first place in the nation to use the powerful Philips MR 7700 scanner solely for research that will prioritize underrepresented groups.

  • Study: ADHD Drugs Delay Bone Healing in Children
    11/13/23

    Children taking psychostimulant drugs prescribed for psychiatric disorders who experience a common childhood fracture take longer to heal than children who don’t take these drugs.

  • Jacobs School Welcomes Undergraduates to Campus
    8/31/23

    The Jacobs School of Medicine and Biomedical Sciences welcomed incoming students to its building on the Buffalo Niagara Medical Campus in downtown Buffalo Aug. 25 as part of Undergraduate Academics Day.

  • Future of Health Care Taking Shape at the Jacobs School
    10/26/23

    The 2023 State of the School address by Allison Brashear, MD, MBA, was titled “Shaping the Future of Health Care” and focused on how the Jacobs School of Medicine and Biomedical Sciences continues to play a leading role in improving the health of the Western New York community and beyond.

  • Study: Global Type 1 Diabetes Burden Remains High
    4/11/23

    The past few years have seen numerous advances in the understanding of how Type 1 diabetes develops and how to manage it, yet the global disease burden remains high.

  • Lipshultz Paper Shows Additional Benefits of Dexrazoxane
    6/21/23

    Steven E. Lipshultz, MD, professor of pediatrics, is senior author on a paper published in the prestigious Journal of Clinical Oncology that shows that for survivors of childhood cancer treated with doxorubicin, dexrazoxane is cardioprotective for at least 18 years.